The curriculum focuses on acquiring specific skills in the interface between immune and metabolic responses in oncological, autoimmune, and genetic pathologies with the aim of developing innovative therapies. Great attention is given to immunosuppressive enzymes that catabolize amino acids and the role of immunometabolic genes in inflammatory and immune diseases, as well as to the understanding of cellular and molecular mechanisms involved in pathologies such as diabetes, obesity, cancer, autoimmune diseases, muscular dystrophy and atrophy, and rare diseases. The approach to various pathologies is translational and aims at identifying biomarkers and potential therapeutic targets.